Hanfei Xu

2.9k total citations
31 papers, 696 citations indexed

About

Hanfei Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Hanfei Xu has authored 31 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Physiology. Recurrent topics in Hanfei Xu's work include Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Genetic Associations and Epidemiology (4 papers) and Epigenetics and DNA Methylation (4 papers). Hanfei Xu is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Genetic Associations and Epidemiology (4 papers) and Epigenetics and DNA Methylation (4 papers). Hanfei Xu collaborates with scholars based in United States, Canada and United Kingdom. Hanfei Xu's co-authors include Ching‐Ti Liu, L. Adrienne Cupples, Andrew Stokes, Douglas P. Kiel, Xiaoyu Zhang, Kerry E Broe, Elizabeth J. Samelson, Mary Bouxsein, Michelle T. Long and Steven K. Boyd and has published in prestigious journals such as JAMA, American Journal of Clinical Nutrition and Hepatology.

In The Last Decade

Hanfei Xu

31 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanfei Xu United States 13 176 165 144 114 113 31 696
Chan‐Young Jung South Korea 15 90 0.5× 128 0.8× 175 1.2× 204 1.8× 62 0.5× 43 756
Eleanor J. Hothersall United Kingdom 11 103 0.6× 81 0.5× 210 1.5× 85 0.7× 175 1.5× 20 827
Maya Rahme Lebanon 14 49 0.3× 193 1.2× 97 0.7× 42 0.4× 33 0.3× 27 766
Bich Tran Australia 16 84 0.5× 73 0.4× 61 0.4× 85 0.7× 24 0.2× 29 514
Rafael Santamaría Spain 15 131 0.7× 27 0.2× 85 0.6× 51 0.4× 74 0.7× 68 772
Yuning Feng China 11 71 0.4× 72 0.4× 76 0.5× 54 0.5× 24 0.2× 42 600
Mohammad Kamgar United States 12 64 0.4× 39 0.2× 77 0.5× 61 0.5× 78 0.7× 31 647
Annalisa Giandalia Italy 17 171 1.0× 37 0.2× 98 0.7× 117 1.0× 27 0.2× 45 743
A. Wolk Sweden 10 80 0.5× 26 0.2× 141 1.0× 128 1.1× 177 1.6× 12 653
Fuzai Yin China 18 106 0.6× 26 0.2× 174 1.2× 152 1.3× 33 0.3× 72 781

Countries citing papers authored by Hanfei Xu

Since Specialization
Citations

This map shows the geographic impact of Hanfei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanfei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanfei Xu more than expected).

Fields of papers citing papers by Hanfei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanfei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanfei Xu. The network helps show where Hanfei Xu may publish in the future.

Co-authorship network of co-authors of Hanfei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hanfei Xu. A scholar is included among the top collaborators of Hanfei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanfei Xu. Hanfei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jingzhou, Brian D. Hobbs, David Sparrow, et al.. (2025). Polygenic Risk Score Added to Conventional Case Finding to Identify Undiagnosed Chronic Obstructive Pulmonary Disease. JAMA. 333(9). 784–784. 9 indexed citations
2.
Zhang, Jingzhou, Matthew Moll, Brian D. Hobbs, et al.. (2024). Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 210(7). 890–899. 5 indexed citations
3.
Lee, Ming-Ming, et al.. (2024). The Upper Limit of Normal Rate of Lung Function Decline in Healthy Adults in the Framingham Heart Study. PubMed. 2(3). 100058–100058. 2 indexed citations
4.
Liu, Jiayan, et al.. (2023). The impact of obesity on lung function measurements and respiratory disease: A Mendelian randomization study. Annals of Human Genetics. 87(4). 174–183. 5 indexed citations
5.
Sanders, Jason L., G. Axelsson, Rachel K. Putman, et al.. (2022). The relationship between interstitial lung abnormalities, mortality, and multimorbidity: a cohort study. Thorax. 78(6). 559–565. 10 indexed citations
6.
Shen, Ning, Theodoros Karantanos, Dun Li, et al.. (2021). DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer. Communications Biology. 4(1). 1289–1289. 39 indexed citations
7.
Xu, Hanfei, Karen Schwander, Michael R. Brown, et al.. (2021). Lifestyle Risk Score: handling missingness of individual lifestyle components in meta-analysis of gene-by-lifestyle interactions. European Journal of Human Genetics. 29(5). 839–850. 3 indexed citations
8.
Liu, Ching‐Ti, David Karasik, Hanfei Xu, et al.. (2021). Genetic variants modify the associations of concentrations of methylmalonic acid, vitamin B-12, vitamin B-6, and folate with bone mineral density. American Journal of Clinical Nutrition. 114(2). 578–587. 9 indexed citations
9.
Long, Michelle T., Xiaoyu Zhang, Hanfei Xu, et al.. (2020). Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. Hepatology. 73(2). 548–559. 77 indexed citations
10.
Sanders, Jason L., Rachel K. Putman, Josée Dupuis, et al.. (2020). The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality. American Journal of Respiratory and Critical Care Medicine. 203(9). 1149–1157. 46 indexed citations
11.
Terzikhan, Natalie, Hanfei Xu, Ahmed Edris, et al.. (2020). Epigenome-wide association study on diffusing capacity of the lung. ERJ Open Research. 7(1). 567–2020. 3 indexed citations
12.
Liu, Ching‐Ti, Xuan Deng, Virginia Fisher, et al.. (2019). Revisit Population-based and Family-based Genotype Imputation. Scientific Reports. 9(1). 1800–1800. 8 indexed citations
13.
Xu, Hanfei, L. Adrienne Cupples, Andrew Stokes, & Ching‐Ti Liu. (2018). Association of Obesity With Mortality Over 24 Years of Weight History. JAMA Network Open. 1(7). e184587–e184587. 114 indexed citations
14.
Lim, Elise, Hanfei Xu, Peitao Wu, et al.. (2018). Network analysis of drug effect on triglyceride-associated DNA methylation. BMC Proceedings. 12(S9). 27–27. 6 indexed citations
15.
Miller, Ezra R., Rachel K. Putman, Alejandro A. Díaz, et al.. (2018). Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society. 16(4). 447–454. 21 indexed citations
16.
Lent, Samantha, Hanfei Xu, Lan Wang, et al.. (2018). Comparison of novel and existing methods for detecting differentially methylated regions. BMC Genetics. 19(S1). 84–84. 16 indexed citations
17.
Sheppard, Vanessa B., Robin L. Walker, Hanfei Xu, et al.. (2018). Spirituality in African-American Breast Cancer Patients: Implications for Clinical and Psychosocial Care. Journal of Religion and Health. 57(5). 1918–1930. 14 indexed citations
18.
Sheppard, Vanessa B., Alejandra Hurtado‐de‐Mendoza, Yun‐Ling Zheng, et al.. (2017). Biospecimen donation among black and white breast cancer survivors: opportunities to promote precision medicine. Journal of Cancer Survivorship. 12(1). 74–81. 18 indexed citations
19.
Xiao, Xuan, Yong Ni, Min Zheng, et al.. (2016). Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects. Bioorganic & Medicinal Chemistry Letters. 26(6). 1508–1511. 7 indexed citations
20.
Chen, Rui, Jie Xiao, Yong Ni, et al.. (2016). Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors. Bioorganic & Medicinal Chemistry. 24(8). 1741–1748. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chan‐Young Jung Breakdown of academic impact, for papers by Eleanor J. Hothersall Breakdown of academic impact, for papers by Maya Rahme Breakdown of academic impact, for papers by Bich Tran Breakdown of academic impact, for papers by Rafael Santamaría Breakdown of academic impact, for papers by Yuning Feng Breakdown of academic impact, for papers by Mohammad Kamgar Breakdown of academic impact, for papers by Annalisa Giandalia Breakdown of academic impact, for papers by A. Wolk Breakdown of academic impact, for papers by Fuzai Yin
Rankless by CCL
2026